However, the incidence rates of pneumonitis were comparable between patients administered with anti-PD-1 and those administered with anti-PD-L1 agents, suggesting that the ability of anti-PD-1 agents to induce ≥ grade 3 pneumonitis is not higher than that of anti-PD-L1 agents (67). The gene discussed is CD274; the disease is pneumonitis.